Day One Biopharmaceuticals Inc (DAWN) — Defensive Interval Ratio
Day One Biopharmaceuticals Inc (DAWN) has a Defensive Interval Ratio of 2747 days as of September 2025. Defensive assets of $425.00 Million (cash $-, short-term investments $408.30 Million, receivables $16.70 Million) cover 2747 days of daily cash needs of $154.70K/day. See Day One Biopharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Day One Biopharmaceuticals Inc Defensive Interval Ratio (2021–2024)
This chart shows how Day One Biopharmaceuticals Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 2747 days, meaning defensive assets of $425.00 Million can fund 2747 days of operations without new revenue. See DAWN equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Day One Biopharmaceuticals Inc (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for Day One Biopharmaceuticals Inc from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Day One Biopharmaceuticals Inc stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2090 days | $420.63 Million | $201.24K/day | $- | $406.75 Million | ▲ +413 days |
| 2023 | 1677 days | $135.56 Million | $80.84K/day | $- | $135.56 Million | ▼ -3969 days |
| 2022 | 5646 days | $257.01 Million | $45.52K/day | $- | $257.01 Million | ▲ +5646 days |
| 2021 | 0 days | $0.00 | $23.72K/day | $- | $0.00 | — |